Difference between revisions of "Ivermectin"
(The Chairman of the Japanese medical association announced in late August 2021 that physicians should use ivermectin to treat Covid-19, but it continues to be suppressed by liberals in the United States.) |
(improved, anti-early treatment bias removed) |
||
| Line 17: | Line 17: | ||
==FDA Stance == | ==FDA Stance == | ||
| − | The FDA has | + | The FDA generally opposes, disparages, and downplays the benefits of early treatment for COVID-19. |
| + | |||
| + | The FDA has publicized isolated reports of patients who have required medical support and been hospitalized after self-medicating with ivermectin intended for horses. Ivermectin has been approved as safe by the FDA and thus can be used when prescribed "off-label" for new uses, such as treating [[COVID-19]]. | ||
| + | |||
| + | Ivermectin tablets are approved at specific doses for some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. Ivermectin is not an anti-viral (a drug for treating viruses). Taking large doses of this drug is dangerous and can cause serious harm. Ivermectin preparations for animals are very different from those approved for humans.<ref>https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19</ref> | ||
==Randomized Trial Negative Results== | ==Randomized Trial Negative Results== | ||
Revision as of 00:05, August 31, 2021
Ivermectin is an off-patent (generic), inexpensive medication which is considered by some to be an effective treatment for COVID-19 as suggested by numerous, constantly updated studies compiled online and by peer-reviewed studies worldwide.[1] The Chairman of the Japanese medical association announced in late August 2021 that physicians should use ivermectin to treat Covid-19, but it continues to be suppressed by liberals in the United States.
Ivermectin has been described as:
| “ | a cheap, safe drug designed to treat parasites that had almost no known side effects ....
“We kind of thought, well, there’s no negatives to taking this,” said [a COVID patient]. “It’s not going to have any really bad side effects. If it could help, why not?” Within 24 hours, her fever was gone. After two days, Coutts felt completely herself again.[2] |
” |
Studies
Researchers at Queen Mary, University of London, published a paper in August 2021 which concluded that:
| “ | from the Bayesian meta-analysis for patients with severe Covid-19, the mean probability of death without ivermectin treatment is 22.9%, whilst with the application of ivermectin treatment it is 11.7%[3] | ” |
In the summer of 2021, a peer-reviewed journal found significant benefits from ivermectin:[4]
| “ | Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally. | ” |
A majority of studies show that ivermectin has been effective for early treatment and prophylactic use.[5]
FDA Stance
The FDA generally opposes, disparages, and downplays the benefits of early treatment for COVID-19.
The FDA has publicized isolated reports of patients who have required medical support and been hospitalized after self-medicating with ivermectin intended for horses. Ivermectin has been approved as safe by the FDA and thus can be used when prescribed "off-label" for new uses, such as treating COVID-19.
Ivermectin tablets are approved at specific doses for some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. Ivermectin is not an anti-viral (a drug for treating viruses). Taking large doses of this drug is dangerous and can cause serious harm. Ivermectin preparations for animals are very different from those approved for humans.[6]
Randomized Trial Negative Results
Double-blind, randomized trial that included 476 patients and conducted at a single site in Cali, Colombia, did not support the use of ivermectin for treatment of mild COVID-19. Larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes. [7]
University of Oxford Study
The University of Oxford in the UK has added ivermectin to the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE) study for the treatment of Covid-19. In small pilot studies, early use of ivermectin was able to lower viral load and the duration of symptoms in some mild Covid-19 patients. [8]
See also
References
- ↑ https://ivmmeta.com/
- ↑ https://www.thecompleteguidetohealth.com/ivermectintestimonials.html
- ↑ https://www.researchgate.net/publication/353973030_Bayesian_hypothesis_testing_and_hierarchical_modelling_of_ivermectin_effectiveness_in_treating_Covid-19
- ↑ https://covid19criticalcare.com/wp-content/uploads/2021/06/Ivermectin_for_Prevention_and_Treatment_of.98040.pdf
- ↑ https://c19ivermectin.com/
- ↑ https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19
- ↑ https://jamanetwork.com/journals/jama/fullarticle/2777389
- ↑ https://www.clinicaltrialsarena.com/news/ivermectin-principle-trial-covid/